Skip to main content
Smart Investors Daily
BlackRock Technology and Private Equity Term Trust logo

NYSE · BTX

BlackRock Technology and Private Equity Term Trust

Healthcare · Biotechnology

$8.42

Down-$0.02 (-0.24%)

Updated Oct 24, 2026, 7:26 PM

SID Score

4.4/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
790.71M
P/E ratio
40.96
Dividend yield
11.13%
52-week range
$6.13 – $9.49
Volume
268.43K
Avg. volume
929.73K

Price performance · BTX

BTX price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 23, 2026

BTX closed at $8.42 after 21 trading sessions, down 6.86% for the selected period.

Last close
$8.42
Period change
-6.86%
Period low
$8.42
Period high
$9.49
Daily close
View OHLC price history
BTX OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 23, 2026$8.42$8.48$8.31$8.42268.43K
Oct 22, 2026$8.43$8.595$8.39$8.44545.86K
Oct 21, 2026$8.68$8.74$8.59$8.73422.88K
Oct 20, 2026$8.50$8.615$8.425$8.60380.25K
Oct 19, 2026$8.61$8.6499$8.465$8.56509.76K
Oct 16, 2026$8.68$8.6999$8.465$8.47542.56K
Oct 15, 2026$8.52$8.695$8.425$8.68581.38K
Oct 14, 2026$8.99$9.10$8.75$8.77571.02K
Oct 13, 2026$9.09$9.16$9.00$9.07963.21K
Oct 12, 2026$9.36$9.36$9.18$9.22316.18K
Oct 9, 2026$9.35$9.425$9.2897$9.401.07M
Oct 8, 2026$9.36$9.38$9.16$9.24596.23K
Oct 7, 2026$9.35$9.4155$9.305$9.40354.17K
Oct 6, 2026$9.40$9.49$9.345$9.49479.99K
Oct 5, 2026$9.24$9.38$9.24$9.38509.77K
Oct 2, 2026$9.30$9.3297$9.22$9.22487.34K
Oct 1, 2026$9.02$9.23$8.98$9.16652.65K
Sep 30, 2026$9.03$9.0498$8.955$8.98611.26K
Sep 29, 2026$8.97$8.99$8.8799$8.95519.66K
Sep 28, 2026$9.01$9.049$8.82$8.86365.29K
Sep 25, 2026$9.04$9.065$8.97$9.04306.06K

Latest BTX news

The latest Smart Investors Daily articles mentioning BTX.

BTX research

Overview

Company profile and research snapshot.

Company profile

BlackRock Technology and Private Equity Term Trust objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust will invest in equity securities issued by mid - and small capitalization companies that the Trust's adviser believes have above-average earnings growth potential.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
BTX recent ratings
DateFirmRatingTarget
Oct 12, 2022Maxim GroupHold—
Dec 29, 2021Cantor FitzgeraldOverweight—
Oct 6, 2021Maxim GroupBuy—
Mar 18, 2019Raymond JamesOutperform—
Feb 21, 2019H.C. WainwrightBuy—
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.